EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|27 Mar 2017||Submitted||Original manuscript|
|10 Jul 2017||Reviewed||Reviewer Report - Kiyoshi Takagi|
|14 Jul 2017||Reviewed||Reviewer Report - Olga G. Goloubeva|
|5 Sep 2017||Author responded||Author comments - Anna Semmlinger|
|Resubmission - Version 2|
|5 Sep 2017||Submitted||Manuscript version 2|
|24 Sep 2017||Reviewed||Reviewer Report - Kiyoshi Takagi|
|20 Mar 2018||Author responded||Author comments - Anna Semmlinger|
|Resubmission - Version 3|
|20 Mar 2018||Submitted||Manuscript version 3|
|21 Mar 2018||Editorially accepted|
|16 Apr 2018||Article published||10.1186/s12885-018-4286-9|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.